Gene therapy for cystic fibrosis airway disease- Is clinical success imminent?

Current Gene Therapy

Volumn 6, Issue 2, 2006, Pages 161-179

  Anson, Donald S ^a,b,c,d   Smith, Gregory J ^a   Parsons, David W ^a,b  

^a WOMEN S AND CHILDREN S HOSPITAL   (Australia)

^b UNIVERSITY OF ADELAIDE   (Australia)

^c FLINDERS UNIVERSITY   (Australia)

^d UNIVERSITY OF SOUTH AUSTRALIA   (Australia)

Author keywords

Adeno associated virus; Airway epithelium; Barrier modification; Gene vector; Host defences; Lentivirus; Pulmonary disease

Indexed keywords

ADENOVIRUS VECTOR; CARBOXYMETHYLCELLULOSE; DECANOIC ACID; DNA; EGTAZIC ACID; FLUOROCARBON; LAURIC ACID DERIVATIVE; LENTIVIRUS VECTOR; LYSOPHOSPHATIDYLCHOLINE; METHYLCELLULOSE; POLIDOCANOL; POLOXAMER; TRANSMEMBRANE CONDUCTANCE REGULATOR;

CLINICAL TRIAL; CYSTIC FIBROSIS; GENE DELIVERY SYSTEM; GENE EXPRESSION; GENE TECHNOLOGY; GENE THERAPY; GENE TRANSFER; GENE VECTOR; GENETIC DISORDER; GENETIC TRANSDUCTION; HOST RESISTANCE; HUMAN; MOLECULAR BIOLOGY; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; PATHOLOGY; RESPIRATORY EPITHELIUM; RESPIRATORY TRACT DISEASE; REVIEW; TARGET CELL; TRANSGENE; TREATMENT OUTCOME; VIRAL GENE DELIVERY SYSTEM;

CLINICAL TRIALS; CYSTIC FIBROSIS; DEPENDOVIRUS; FEASIBILITY STUDIES; GENE THERAPY; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; HUMANS; LENTIVIRUS; MODELS, BIOLOGICAL; TRANSDUCTION, GENETIC; TREATMENT OUTCOME;

ADENO-ASSOCIATED VIRUS; ADENOVIRIDAE; LENTIVIRUS;

EID: 33646191190     PISSN: 15665232     EISSN: None     Source Type: Journal    
DOI: 10.2174/156652306776359496     Document Type: Review

References (226)

1. Afione, S.A., Conrad, C.K., Kearns, W.G., Chunduru, S., Adams, R., Reynolds, T.C., Guggino, W.B., Cutting, G.R., Carter, B.J., and Flotte, T.R. (1996) In vivo model of adeno-associated virus vector persistence and rescue. J. Virol. 70: 3235-3241.
2. Aitken, M.L., Moss, R.B., Waltz, D.A., Dovey, M.E., Tonelli, M.R., McNamara, S.C., Gibson, R.L., Ramsey, B.W., Carter, B.J., and Reynolds, T.C. (2001) A phase I study of aerosolized administration of tgAAVCF to cystic fibrosis subjects with mild lung disease. Hum. Gene Ther. 12: 1907-1916.
3. Akabas, M.H. (2000) Cystic fibrosis transmembrane conductance regulator. Structure and function of an epithelial chloride channel. J. Biol. Chem. 275: 3729-3732.
4. Alton, E.W. United Kingdom Cystic Fibrosis Gene Therapy Consortium. (2004) Use of nonviral vectors for cystic fibrosis gene therapy. Proc. Am. Thorac. Soc. 1: 296-301.
5. Anson DS. (2004) The use of retroviral vectors for gene therapy-what are the risks? A review of retroviral pathogenesis and its relevance to retroviral vector-mediated gene delivery. Genet. Vaccines Ther. 2: 9.
6. Aurora, P., Gustafsson, P., Bush, A., Lindblad, A., Oliver, C., Wallis, C.E., and Stocks, J. (2004) Multiple breath inert gas washout as a measure of ventilation distribution in children with cystic fibrosis. Thorax 59: 1068-1073.
7. Baconnais, S., Delavoie, F., Zahm, J.M., Milliot, M., Terryn, C., Castillon, N., Banchet, V., Michel, J., Danos, O., Merten, M., Chinet, T., Zierold, K., Bonnet, N., Puchelle, E., and Balossier, G. (2005) Abnormal ion content, hydration and granule expansion of the secretory granules from cystic fibrosis airway glandular cells. Exp. Cell Res. [Epub ahead of print].
8. Ballmann, M., and von der Hardt, H. (2002) Hypertonic saline and recombinant human DNase: a randomised cross-over pilot study in patients with cystic fibrosis. J. Cyst. Fibros. 1: 35-37.
9. Bals, R., Weiner, D.J., Meegalla, R.L., Accurso, F., and Wilson, J.M. (2001) Salt-independent abnormality of antimicrobial activity in cystic fibrosis airway surface fluid. Am. J. Resp. Cell Mol. Biol. 25: 21-25.
10. Beck, S.E., Jones, L.A., Chesnut, K., Walsh, S.M., Reynolds, T.C., Carter, B.J., Askin, F.B., Flotte, T.R., and Guggino, W.B. (1999) Repeated delivery of adeno-associated virus vectors to the rabbit airway. J. Virol. 73: 9446-9455.
11. Bishop, A.E. (2004) Pulmonary epithelial stem cells. Cell Prolif. 37: 89-96.
12. Bobadilla, J.L., Macek, M. Jr., Fine, J.P., and Farrell, P.M. (2002) Cystic fibrosis: a worldwide analysis of CFTR mutations - correlation with incidence data and application to screening. Hum. Mutat 19: 575-606.
13. Bois, E., Feingold, J., Demenais, F., Runavot, Y., Jehanne. M., and Toudic. L. (1978) Cluster of cystic fibrosis cases in a limited area of Brittany (France). Clin. Genet. 14: 73-76.
14. Borthwick, D. W., Shahbazian, M., Krantz, Q.T., Dorin, J.R., and Randell, S.H. (2001) Evidence for stem-cell niches in the tracheal epithelium. Am. J. Respir. Cell Mol. Biol. 24: 662-70.
15. Boucher, R.C. (1999) Status of gene therapy for cystic fibrosis lung disease. J. Clin. Invest. 103: 441-445.
16. Bowie, A.G., and Haga, I.R. (2005) The role of Toll-like receptors in the host response to viruses. Mol. Immunol. 42: 859-867.
17. Broackes-Carter, F.C., Mouchel, N., Gill, D., Hyde, S., Bassett, J., and Harris, A. (2002) Temporal regulation of CFTR expression during ovine lung development: implications for CF gene therapy. Hum. Mol. Genet. 11: 125-131.
18. Brochiero, E., Dagenais, A., Prive, A., Berthiaume, Y., and Grygorczyk, R. (2004) Evidence of a functional CFTR Cl(-) channel in adult alveolar epithelial cells. Am. J. Physiol. Lung Cell. Mol. Physiol. 287: L382-392.
19. Brody, A.S., Klein, J.S., Molina, P.L., Quan, J., Bean, J.A., and Wilmott, R.W. (2004) High-resolution computed tomography in young patients with cystic fibrosis: distribution of abnormalities and correlation with pulmonary function tests. J. Pediatr. 145: 32-38.
20. Brown. J., Mellis, C.M., and Wood, R.E. (1985) Edetate sodium aerosol in Pseudomonas lung infection in cystic fibrosis. Am. J. Dis. Child. 139: 836-839.
21. Chow, Y.H., Plumb, J., Wen, Y., Steer, B.M., Lu, Z., Buchwald, M., and Hu, J. (2000) Targeting transgene expression to airway epithelia and submucosal glands, prominent sites of human CFTR expression. Mol. Ther. 2: 359-367.
22. Chu, C.S., Trapnell, B.C., Curristin, S.M., Cutting, G.R., and Crystal, R.G. (1992) Extensive posttranscriptional deletion of the coding sequences for part of nucleotide-binding fold 1 in respiratory epithelial mRNA transcripts of the cystic fibrosis transmembrane conductance regulator gene is not associated with the clinical manifestations of cystic fibrosis. J. Clin. Invest. 785-790.
23. Chu, Q., St George, J.A., Lukason, M., Cheng, S.H., Scheule, R.K., and Eastman, S.J. (2001) EGTA enhancement of adenovirus-mediated gene transfer to mouse tracheal epithelium in vivo. Hum. Gene Ther. 12: 455-467.
24. Coakley, R.D., Grubb, B.R., Paradiso, A.M., Gatzy, J.T., Johnson, L.G., Kreda, S.M., O'Neal, W.K., and Boucher, R.C. (2003) Abnormal surface liquid pH regulation by cultured cystic fibrosis bronchial epithelium. Proc. Natl. Acad. Sci. USA 100: 16083-16088.
25. Coleman, F.T., Mueschenborn, S., Meluleni, G., Ray, C., Carey, V.J., Vargas, S.O., Cannon, C.L., Ausubel, F.M., and Pier, G.B. (2003) Hypersusceptibility of cystic fibrosis mice to chronic Pseudomonas aeruginosa oropharyngeal colonization and lung infection. Proc. Natl. Acad. Sci. USA 100: 1949-1954.
26. Conrad, C.K., Allen, S.S., Afione, S.A., Reynolds, T.C., Beck, S.E., Fee-Maki, M., Barrazza-Ortiz, X., Adams, R., Askin, F.B., Carter, B.J., Guggino, W.B., and Flotte, T.R. (1996) Safety of single-dose administration of an adeno-associated virus (AAV)-CFTR vector in the primate lung. Gene Ther. 3: 658-668.
27. Copreni, E., Penzo, M., Carrabino, S., and Conese, M. (2004) Lentivirus-mediated gene transfer to the respiratory epithelium: a promising approach to gene therapy of cystic fibrosis. Gene Ther. 11 Suppl 1:S67-75.
28. Coyne, C.B., Kelly, M.M., Boucher, R.C., and Johnson, L.G. (2000) Enhanced epithelial gene transfer by modulation of tight junctions with sodium caprate. Am. J. Respir. Cell Mol. Biol. 23: 602-609.
29. Davies, J.C., Davies, M., McShane, D., Smith, S., Chadwick, S., Jaffe, A., Farley, R., Collins, L., Bush, A., Scallon, M., Pepper, J., Geddes, D.M., and Alton, E.W. (2005) Potential difference measurements in the lower airway of children with and without cystic fibrosis. Am. J. Respir. Crit. Care Med. 171: 1015-1019.
30. de Gracia, J., Mata, F., Alvarez, A., Casals, T., Gatner, S., Vendrell, M., de la Rosa, D., Guarner, L., and Hermosilla, E. (2005) Genotype-phenotype correlation for pulmonary function in cystic fibrosis. Thorax 60: 558-563.
31. de Jong, P.A., Nakano, Y., Hop, W.C., Long, F.R., Coxson, H.O., Pare, P.D., and Tiddens, H.A. (2005) Changes in airway dimensions on computed tomography scans of children with cystic fibrosis. Am. J. Respir. Crit. Care Med. 172: 218-224.
32. Desgeorges, M., Megarbane, A., Guittard, C., Carles, S., Loiselet, J., Demaille, J., and Claustres, M. (1997) Cystic fibrosis in Lebanon: distribution of CFTR mutations among Arab communities. Hum. Genet. 100: 279-283.
33. Deterding, R., Retsch-Bogart, G., Milgram, L., Gibson, R., Daines, C., Zeitlin, P.L., Milla, C., Marshall, B., Lavange, L., Engels, J., Mathews, D., Gorden, J., Schaberg, A., Williams, J., and Ramsey, B. (2005) Cystic Fibrosis Foundation Therapeutics Development Network. Safety and tolerability of denufosol tetrasodium inhalation solution, a novel P2Y2 receptor agonist: results of a phase 1/phase 2 multicenter study in mild to moderate cystic fibrosis. Pediatr. Pulmonol. 39: 339-48.
34. Doucet, L., Mendes, F., Montier, T., Delepine, P., Penque, D., Ferec, C., and Amaral, MD. (2003) Applicability of different antibodies for the immunohistochemical localization of CFTR in respiratory and intestinal tissues of human and murine origin. J. Histochem. Cytochem. 51: 1191-1199.
35. Drumm, M.L., Pope, H.A., Cliff, W.H., Rommens, J.M., Marvin, S.A., Tsui, L.C., Collins, F.S., Frizzell, R.A., and Wilson, J.M. (1990) Correction of the cystic fibrosis defect in vitro by retrovirus-mediated gene transfer. Cell 62: 1227-1233. Erratum in: Cell 74: 215.
36. Duan, D., Yue, Y., Yan, Z., McCray, P.B. Jr., and Engelhardt, J.F. (1998) Polarity influences the efficiency of recombinant adenoassociated virus infection in differentiated airway epithelia. Hum. Gene Ther. 9: 2761-2776.
37. Duan, D., Sharma, P., Yang, J., Yue, Y., Dudus, L., Zhang, Y., Fisher, K.J., and Engelhardt, J.F. (1999) Circular intermediates of recombinant adeno-associated virus have defined structural characteristics responsible for long-term episomal persistence in muscle tissue. J. Virol. 72: 8568-8577.
38. Duan, D., Yue, Y., Yan, Z., Yang, J., and Engelhardt, J.F. (2000) Endosomal processing limits gene transfer to polarized airway epithelia by adeno-associated virus. J. Clin. Invest. 105: 1573-1587.
39. Duan, D., Yue, Y., and Engelhardt, J.F. (2001) Expanding AAV packaging capacity with trans-splicing or overlapping vectors: a quantitative comparison. Mol. Ther. 4: 383-391.
40. Engelhardt, J.F., Yankaskas, J.R., Ernst, S.A., Yang, Y., Marino, C.R., Boucher, R.C., Cohn, J.A., and Wilson, J.M. (1992) Submucosal glands are the predominant site of CFTR expression in the human bronchus. Nat. Genet. 2: 240-248.
41. Engelhardt, J.F., Zepeda, M., Cohn, J.A., Yankaskas, J.R., and Wilson, J.M. (1994) Expression of the cystic fibrosis gene in adult human lung. J. Clin. Invest. 93: 737-749.
42. Farmen, S.L., Karp, P.H., Ng, P., Palmer, D.J., Koehler, D.R., Hu, J., Beaudet, A.L., Zabner, J., and Welsh, M.J. (2005) Gene transfer of CFTR to airway epithelia: low levels of expression are sufficient to correct Cl- transport and overexpression can generate basolateral CFTR. Am. J. Physiol. Lung Cell. Mol. Physiol. 289: L1123-30.
43. Farrell, P.M. (2000) Improving the health of patients with cystic fibrosis through newborn screening. Wisconsin Cystic Fibrosis Neonatal Screening Study Group. Adv. Pediatr. 47: 79-115.
44. Ferrari, S., Geddes, D.M., and Alton, E.W. (2002) Barriers to and new approaches for gene therapy and gene delivery in cystic fibrosis. Adv. Drug Deliv. Rev. 54: 1373-1393.
45. Ferrari, S, Griesenbach, U., Geddes, D.M., and Alton, E. (2003) Immunological hurdles to lung gene therapy. Clin. Exp. Immunol. 132: 1-8.
46. Ferrari, S., Griesenbach, U., Shiraki-Iida, T., Shu, T., Hironaka, T., Hou, X., Williams, J., Zhu, J., Jeffery, P.K., Geddes, D.M., Hasegawa, M., and Alton, E.W. (2004) A defective nontransmissible recombinant Sendai virus mediates efficient gene transfer to airway epithelium in vivo. Gene Ther. 11: 1659-1664.
47. Fischer, A.C., Beck, S.E., Smith, C.I., Laube, B.L., Askin, F.B., Guggino, S.E., Adams, R.J., Flotte, T.R., and Guggino, W.B. (2003) Successful transgene expression with serial doses of aerosolized rAAV2 vectors in rhesus macaques. Mol. Ther. 8: 918-926.
48. Flotte, T.R., Afione, S.A., Solow, R., Drumm, M.L., Markakis, D., Guggino, W.B., Zeitlin, P.L., and Carter, B.J. (1993a) Expression of the cystic fibrosis transmembrane conductance regulator from a novel adeno-associated virus promoter. J. Biol. Chem. 268: 3781-3790.
49. Flotte, T.R., Afione, S.A., Conrad, C., McGrath, S.A., Solow, R., Oka, H., Zeitlin, P.L., Guggino, W.B., and Carter, B.J. (1993b) Stable in vivo expression of the cystic fibrosis transmembrane conductance regulator with an adeno-associated virus vector. Proc. Natl. Acad. Sci. USA 90: 10613-10617.
50. Flotte, T.R., and Laube, B.L. (2001) Gene therapy in cystic fibrosis. Chest 120 (3 Suppl): 124S-131S.
51. Flotte, T.R., Zeitlin, P.L., Reynolds, T.C., Heald, A.E., Pedersen, P., Beck, S., Conrad, C.K., Brass-Ernst, L., Humphries, M., Sullivan, K., Wetzel, R., Taylor, G., Carter, B.J., and Guggino, W.B. (2003) Phase I trial of intranasal and endobronchial administration of a recombinant adeno-associated virus serotype 2 (rAAV2)-CFTR vector in adult cystic fibrosis patients: a two-part clinical study. Hum. Gene Ther. 14: 1079-1088.
52. Flotte, T.R. (2004) Gene therapy progress and prospects: recombinant adeno-associated virus (rAAV) vectors. Gene Ther. 11: 805-810.
53. Flotte, T.R. (2005) Recent developments in recombinant AAV-mediated gene therapy for lung diseases. Curr. Gene Ther. 5: 361-366.
54. Flotte, T.R., Schwiebert, E.M., Zeitlin, P.L., Carter, B.J., and Guggino, W.B. (2005) Correlation between DNA transfer and cystic fibrosis airway epithelial cell correction after recombinant adeno-associated virus serotype 2 gene therapy. Hum. Gene Ther. 16: 921-928.
55. Frossard, P.M., Lestringant, G., Girodon, E., Goossens, M., and Dawson, K.P. (1999) Determination of the prevalence of cystic fibrosis in the United Arab Emirates by genetic carrier screening. Clin. Genet. 55: 496-497.
56. Gabriel, S.E., Brigman, K.N., Koller, B.H., Boucher, R.C., and Stutts, M.J. (1994) Cystic fibrosis heterozygote resistance to cholera toxin in the cystic fibrosis mouse model. Science 266: 107-109.
57. Gadsby, D.C., and Nairn, A.C. (1999) Regulation of CFTR Cl- ion channels by phosphorylation and dephosphorylation. Adv. Second Messenger Phosphoprotein Res. 33: 79-106.
58. Ganesh, L., Burstein, E., Guha-Niyogi, A., Louder, M.K., Mascola, J.R., Klomp, L.W., Wijmenga, C., Duckett, C.S., and Nabel, G.J. (2003) The gene product Murr1 restricts HIV-1 replication in resting CD4+ lymphocytes. Nature 426: 853-857.
59. Giangreco, A., Reynolds, S.D., and Stripp, B.R. (2002) Terminal bronchioles harbor a unique airway stem cell population that localizes to the bronchoalveolar duct junction. Am. J. Pathol. 161: 173-182.
60. Giangreco, A., Shen, H., Reynolds, S.D., and Stripp, B.R. (2004) Molecular phenotype of airway side population cells. Am. J. Physiol. Lung Cell Mol. Physiol. 286: L624-L630.
61. Glover, D.J., Lipps, H.J., and Jans, D.A. (2005) Towards safe, non-viral therapeutic gene expression in humans. Nat. Rev. Genet. 6: 299-310.
62. Goddard, C.A., Ratcliff, R., Anderson, J.R., Glenn, E., Brown, S., Gill, D.R., Hyde, S.C., MacVinish, L.J., Huang, L., Higgins, C.F., Cuthbert, A.W., Evans, M.J., and Colledge, W.H. (1997) A second dose of a CFTR cDNA-liposome complex is as effective as the first dose in restoring cAMP-dependent chloride secretion to null CF mice trachea. Gene Ther. 4: 1231-1236.
63. Goldman, M.J., Lee, P.S., Yang, J.S., and Wilson, J.M. (1997) Lentiviral vectors for gene therapy of cystic fibrosis. Hum. Gene Ther. 8: 2261-2268.
64. Greber, U.F., Willetts, M., Webster, P., and Helenius, A. (1993) Stepwise dismantling of adenovirus 2 during entry into cells. Cell 75: 477-486.
65. Greene, W.C. (2004) Redistricting the retroviral restriction factors. Nat. Med. 10: 778-780.
66. Griesenbach, U., Geddes, D.M., and Alton, E.W. (2004) Advances in cystic fibrosis gene therapy. Curr. Opin. Pulm. Med. 10: 542-546.
67. Griesenbach, U., and Boyd, A.C. (2005) Pre-clinical and clinical endpoint assays for cystic fibrosis gene therapy. J. of Cystic Fibrosis 4: 89-100.
68. Grimm, D., Kern, A., Rittner, K., and Kleinschmidt, J.A. (1998) Novel tools for production and purification of recombinant adenoassociated virus vectors. Hum. Gene Ther. 9: 2745-2760.
69. Grimm, D., and Kay, M.A. (2003) From virus evolution to vector revolution: use of naturally occurring serotypes of adeno-associated virus (AAV) as novel vectors for human gene therapy. Curr. Gene Ther. 3: 281-304.
70. Grimm, D., Kay, M.A., and Kleinschmidt, J.A. (2003) Helper virus-free, optically controllable, and two-plasmid-based production of adeno-associated virus vectors of serotypes 1 to 6. Mol. Ther. 7: 839-850.
71. Grosse, S.D., Boyle, C.A., Botkin, J.R., Comeau, A.M., Kharrazi, M., Rosenfeld, M., and Wilfond, B.S. (2004) CDC. Newborn screening for cystic fibrosis: evaluation of benefits and risks and recommendations for state newborn screening programs. MMWR Recomm. Rep. 53(RR-13): 1-36.
72. Grubb, B.R., Pickles, R.J., Ye, H., Yankaskas, J.R., Vick, R.N., Engelhardt, J.F., Wilson, J.M., Johnson, L.G., and Boucher, R.C. (1994) Inefficient gene transfer by adenovirus vector to cystic fibrosis airway epithelia of mice and humans. Nature 371: 802-806.
73. Halbert, C.L., Standaert, T.A., Aitken, M.L., Alexander, I.E., Russell, D.W., and Miller, A.D. (1997) Transduction by adeno-associated virus vectors in the rabbit airway: efficiency, persistence, and readministration. J. Virol. 71: 5932-5941.
74. Halbert. C.L., Standaert, T.A., Wilson, C.B., and Miller, A.D. (1998) Successful readministration of adeno-associated virus vectors to the mouse lung requires transient immunosuppression during the initial exposure. J. Virol. 72: 9795-9805.
75. Halbert, C.L., Rutledge, E.A., Allen, J.M., Russell, D.W., and Miller, A.D. (2000) Repeat transduction in the mouse lung by using adeno-associated virus vectors with different serotypes. J. Virol. 74: 1524-1532.
76. Halbert, C.L., Allen, J.M., and Miller, A.D. (2001) Adeno-associated virus type 6 (AAV6) vectors mediate efficient transduction of airway epithelial cells in mouse lungs compared to that of AAV2 vectors. J. Virol. 75: 6615-6624.
77. Halbert, C.L., Allen, J.M., and Miller AD. (2002) Efficient mouse airway transduction following recombination between AAV vectors carrying parts of a larger gene. Nat. Biotechnol. 20: 697-701.
78. Harvey, B.G., Leopold, P.L., Hackett, N.R., Grasso, T.M., Williams, P.M., Tucker, A.L., Kaner, R.J., Ferris, B., Gonda, I., Sweeney, T.D., Ramalingam, R., Kovesdi, I., Shak, S., and Crystal, R.G. (1999) Airway epithelial CFTR mRNA expression in cystic fibrosis patients after repetitive administration of a recombinant adenovirus. J. Clin. Invest. 104: 1245-1255.
79. Hay, J.G., McElvaney, N.G., Herena, J., and Crystal, R.G. (1995) Modification of nasal epithelial potential differences of individuals with cystic fibrosis consequent to local administration of a normal CFTR cDNA adenovirus gene transfer vector. Hum. Gene Ther. 6: 1487-1496.
80. Hirschl, R.B., Pranikoff, T., Gauger, P., Schreiner, R.J., Dechert, R., and Bartlett, R.H. (1995) Liquid ventilation in adults, children, and full-term neonates. Lancet 346: 1201-1202.
81. Hirsh, A.J., Sabater, J.R., Zamurs, A., Smith, R.T., Paradiso, A.M., Hopkins, S., Abraham, W.M., and Boucher, R.C. (2004) Evaluation of second generation amiloride analogs as therapy for cystic fibrosis lung disease. J. Pharmacol. Exp. Ther. 311: 929-938.
82. Hong, K.U., Reynolds, S.D., Giangreco, A., Hurley, C.M., and Stripp, B.R. (2001) Clara cell secretory protein-expressing cells of the airway neuroepithelial body microenvironment include a label-retaining subset and are critical for epithelial renewal after progenitor cell depletion. Am. J. Respir. Cell Mol. Biol. 24: 671-681.
83. Hong, K.U., Reynolds, S.D., Watkins, S., Fuchs, E., and Stripp, B.R. (2004) Basal cells are a multipotent progenitor capable of renewing the bronchial epithelium. Am. J. Pathol. 164: 577-588.
84. Hudson VM. (2004) New insights into the pathogenesis of cystic fibrosis: pivotal role of glutathione system dysfunction and implications for therapy. Treat Respir. Med. 3: 353-363.
85. Hyde, S.C., Emsley, P., Hartshorn, M.J., Mimmack, M.M., Gileadi, U., Pearce, S.R., Gallagher, M.P., Gill, D.R., Hubbard. R.E., and Higgins, C.F. (1990) Structural model of ATP-binding proteins associated with cystic fibrosis, multidrug resistance and bacterial transport. Nature 346: 362-365
86. Jayaraman, S., Joo, N.S., Reitz, B., Wine, J.J., and Verkman, A.S. (2001) Submucosal gland secretions in airways from cystic fibrosis patients have normal [Na(+)] and pH but elevated viscosity. Proc. Natl. Acad. Sci. USA 98: 8119-8123.
87. Jenke, A.C., Stehle, I.M., Herrmann, F., Eisenberger, T., Baiker, A., Bode, J., Fackelmayer, F.O., and Lipps, H.J. (2004) Nuclear scaffold/ matrix attached region modules linked to a transcription unit are sufficient for replication and maintenance of a mammalian episome. Proc. Natl. Acad. Sci. USA 101: 11322-11327.
88. Jiang, C., O'Connor, S.P., Armentano, D., Berthelette, P.B., Schiavi, S.C., Jefferson, D.M., Smith, A.E., Wadsworth, S.C., and Cheng, S.H. (1996) Ability of adenovirus vectors containing different CFTR transcriptional cassettes to correct ion transport defects in CF cells. Am. J. Physiol. 271: L527-L537.
89. Jobe, A.H., Ueda, T., Whitsett, J.A., Trapnell, B.C., and Ikegarni, M. (1996) Surfactant enhances adenovirus-mediated gene expression in rabbit lungs. Gene Ther. 3: 775-779.
90. Johnson, L.G., Olsen, J.C., Sarkadi, B., Moore, K.L., Swanstrom, R., and Boucher, R.C. (1992) Efficiency of gene transfer for restoration of normal airway epithelial function in cystic fibrosis. Nat. Genet. 2: 21-25.
91. Johnson, L.G., Boyles, S.E., Wilson, J., and Boucher, R.C. (1995) Normalization of raised sodium absorption and raised calcium-mediated chloride secretion by adenovirus-mediated expression of cystic fibrosis transmembrane conductance regulator in primary human cystic fibrosis airway epithelial cells. J. Clin. Invest. 95: 1377-1382.
92. Johnson, L.G., Olsen, J.C., Naldini, L., and Boucher, R.C. (2000) Pseudo-typed human lentiviral vector-mediated gene transfer to airway epithelia in vivo. Gene Ther. 7: 568-574.
93. Johnson, L.G., Vanhook, M.K., Coyne, C.B., Haykal-Coates, N., and Gavett, S.H. (2003) Safety and efficiency of modulating paracellular permeability to enhance airway epithelial gene transfer in vivo. Hum. Gene Ther. 14: 729-747.
94. Kabra, S.K., Kabra, M., Lodha, R., Shastri, S., Ghosh, M., Pandey, R.M., Kapil, A., Aggarwal, G., and Kapoor, V. (2003) Clinical profile and frequency of delta f508 mutation in Indian children with cystic fibrosis. Indian Pediatr. 40: 612-619.
95. Kalin, N., Claass, A., Sommer, M., Puchelle, E., and Tummler, B. (1999) DeltaF508 CFTR protein expression in tissues from patients with cystic fibrosis. J. Clin. Invest. 103: 1379-1389.
96. Katkin, J.P., Husser, R.C., Langston, C., and Welty, S.E. (1997) Exogenous surfactant enhances the delivery of recombinant adenoviral vectors to the lung. Hum. Gene Ther. 8: 171-176.
97. Kerem, B., Rommens, J.M., Buchanan, J.A., Markiewicz, D., Cox, T.K., Chakravarti, A., Buchwald, M., and Tsui, L.-C. (1989) Identification of the cystic fibrosis gene: genetic analysis. Science 245: 1073-1080.
98. Kerem, E., Kalman, Y.M., Yahav, Y., Shoshani, T., Abeliovich, D., Szeinberg, A., Rivlin, J., Blau, H., Tal, A., Ben-Tur, L., Springer, C., Augarten, A., Godfrey, S., Lerer, I., Branski, D., Friedman, M., and Kerem, B.S. (1995) Highly variable incidence of cystic fibrosis and different mutation distribution among different Jewish ethnic groups in Israel. Hum. Genet. 96: 193-7.
99. Kerem, E., Conway, S., Elborn, S., and Heijerman, H. (2005) Consensus Committee. Standards of care for patients with cystic fibrosis: a European consensus. J. Cyst. Fibros. 4: 7-26.
100. Keswani, S.G., and Crombleholme, T.M. (2004) Gene transfer to the tracheobronchial tree: implications for fetal gene therapy for cystic fibrosis. Semin. Pediatr. Surg. 13: 44-52.
101. Kinsey, B.M., Densmore, C.L., and Orson, F.M. (2005) Non-viral gene delivery to the lungs. Curr. Gene Ther. 5: 181-194.
102. Kleeberger, W., Versmold, A., Rothamel, T., Glockner, S., Bredt, M., Haverich, A., Lehmann, U., and Kreipe, H. (2003) Increased chimerism of bronchial and alveolar epithelium in human lung allografts undergoing chronic injury. Am. J. Pathol. 162: 1487-1494.
103. Klink, D., Schindelhauer, D., Laner, A., Tucker, T., Bebok, Z., Schwiebert, E.M., Boyd, A.C., and Scholte, B.J. (2004) Gene delivery systems-gene therapy vectors for cystic fibrosis. J. Cyst. Fibros. 3 (Suppl 2): 203-212.
104. Kobayashi, M., Iida, A., Ueda, Y., and Hasegawa, M. (2003) Pseudotyped lentivirus vectors derived from simian immunodeficiency virus SIVagm with envelope glycoproteins from paramyxovirus. J. Virol. 77: 2607-2614.
105. Kobinger, G.P., Weiner, D.J., Yu, Q.C., and Wilson, J.M. (2001) Filovirus-pseudotyped lentiviral vector can efficiently and stably transduce airway epithelia in vivo. Nat. Biotechnol. 19: 225-230.
106. Koehler, D.R., Sajjan, U., Chow, Y.H., Martin, B., Kent, G., Tanswell, A.K., McKerlie, C., Forstner, J.F., and Hu, J. (2003) Protection of Cftr knockout mice from acute lung infection by a helper-dependent adenoviral vector expressing Cftr in airway epithelia. Proc. Natl. Acad. Sci. USA 100: 15364-15369.
107. Koehler, D.R., Frndova, H., Leung, K., Louca, E., Palmer, D., Ng, P., McKerlie, C., Cox, P., Coates, A.L., and Hu, J. (2005) Aerosol delivery of an enhanced helper-dependent adenovirus formulation to rabbit lung using an intratracheal catheter. J. Gene Med [Epub ahead of print].
108. Kogan, I., Ramjeesingh, M., Li, C., Kidd, J.F., Wang, Y., Leslie, E.M., Cole, S.P., and Bear, C.E. (2003) CFTR directly mediates nucleotide-regulated glutathione flux. EMBO J. 22: 1981-1989.
109. Konstan, M.W., Davis, P.B., Wagener, J.S., Hilliard, K.A., Stern, R.C., Milgram, L.J., Kowalczyk, T.H., Hyatt, S.L., Fink, T.L., Gedeon, C.R., Oette, S.M., Payne, J.M., Muhammad, O., Ziady, A.G., Moen, R.C., and Cooper, M.J. (2004) Compacted DNA nanoparticles administered to the nasal mucosa of cystic fibrosis subjects are safe and demonstrate partial to complete cystic fibrosis transmembrane regulator reconstitution. Hum. Gene Ther. 15: 1255-1269.
110. Kotton, D.N., Ma, B.Y., Cardoso, W.V., Sanderson, E.A., Summer, R.S., Williams, M.C., and Fine, A. (2001) Bone marrow-derived cells as progenitors of lung alveolar epithelium. Development 128: 5181-5188.
111. Kozlova, I., Vanthanouvong, V., Almgren, B., Hogman, M., and Roomans, G.M. (2005) Elemental composition of airway surface liquid in the pig determined by x-ray microanalysis. Am. J. Respir. Cell Mol. Biol. 32: 59-64.
112. Krause, D.S., Theise, N.D., Collector, M.I., Henegariu, O., Hwang, S., Gardner, R., Neutzel, S., and Sharkis, S.J. (2001) Multi-organ, multilineage engraftment by a single bone marrow-derived stem cell. Cell 105: 369-377.
113. Kreda, S.M., Mall, M., Mengos, A., Rochelle, L., Yankaskas, J., Riordan, J.R., and Boucher, R.C. (2005) Characterization of wild-type and deltaF508 cystic fibrosis transmembrane regulator in human respiratory epithelia. Mol. Biol. Cell. 16: 2154-2167.
114. Kunzelmann, K., and Mall, M. (2003) Pharmacotherapy of the ion transport defect in cystic fibrosis: role of purinergic receptor agonists and other potential therapeutics. Am. J. Respir. Med. 2: 299-309.
115. Larson, J.E., and Cohen, J.C. (2005) Developmental paradigm for early features of cystic fibrosis. Pediatr. Pulmonol. 40: 371-377.
116. Lee, T.W., Matthews, D.A., and Blair, G.E. (2005) Novel molecular approaches to cystic fibrosis gene therapy. Biochem. J 387: 1-15.
117. Lei, D.C., Kunzelmann, K., Koslowsky, T., Yezzi, M.J., Escobar, L.C., Xu, Z., Ellison, A.R., Rommens, J.M., Tsui, L.C., Tykocinski, M., and Gruenert, D.C. (1996) Episomal expression of wild-type CFTR corrects cAMP-dependent chloride transport in respiratory epithelial cells. Gene Ther. 3: 427-436.
118. Limberis, M., Anson, D.S., Fuller, M., and Parsons, D.W. (2002) Recovery of airway cystic fibrosis transmembrane conductance regulator function in mice with cystic fibrosis after single-dose lentivirus-mediated gene transfer. Hum. Gene Ther. 13: 1961-1970.
119. Liu, X., Luo, M., Zhang, L.N., Yan, Z., Zak, R., Ding, W., Mansfield, S.G., Mitchell, L.G., and Engelhardt, J.F. (2005) Spliceosome-Mediated RNA Trans-Splicing with Recombinant Adeno-Associated Virus Partially Restores Cystic Fibrosis Transmembrane Conductance Regulator Function to Polarized Human Cystic Fibrosis Airway Epithelial Cells. Hum. Gene Ther. [Epub ahead of print].
120. Lisby, D.A., Ballard, P.L., Fox, W.W., Wolfson, M.R., Shaffer, T.H., and Gonzales, L.W. (1997) Enhanced distribution of adenovirus-mediated gene transfer to lung parenchyma by perfluorochemical liquid. Hum. Gene Ther. 8: 919-928.
121. Lucotte, G., and Hazout, S. (1995) Geographic and ethnic distributions of the more frequent cystic fibrosis mutations in Europe show that a founder effect is apparent for several mutant alleles. Hum. Biol. 67: 562-576.
122. McCarty, D.M., Young, S.M. Jr., and Samulski, R.J. (2004) Integration of a adeno-associated virus (AAV) and recombinant AAV vectors. Annu. Rev. Genet. 38: 819-845.
123. McCray, P.B. Jr., Wang, G., Kline, J.N., Zabner, J., Chada, S., Jolly, D.J., Chang, S.M., and Davidson, B.L. (1997) Alveolar macrophages inhibit retrovirus-mediated gene transfer to airway epithelia. Hum. Gene Ther. 8: 1087-1093.
124. McGrath, S.A., Basu, A., and Zeitlin, P.L. (1993) Cystic fibrosis gene and protein expression during fetal lung development. Am. J. Respir. Cell Mol. Biol. 8: 201-208.
125. McKone, E.F., Emerson, S.S., Edwards, K.L., and Aitken, M.L. (2003) Effect of genotype on phenotype and mortality in cystic fibrosis: a retrospective cohort study. Lancet 361: 1671-1676.
126. + absorption produces cystic fibrosis-like lung disease in mice. Nat. Med. 10: 487-493.
127. Martin, G.P., Marriott, C., and Kellaway, I.W. (1978) Direct effect of bile salts and phospholipids on the physical properties of mucus. Gut 19: 103-107.
128. Massie, J., Gaskin, K., Van Asperen, P., and Wilcken, B. (2000) Sweat testing following newborn screening for cystic fibrosis. Pediatr. Pulmonol. 29: 452-456.
129. Medina, M.F., Kobinger, G.P., Rux, J., Gasmi, M., Looney, D.J., Bates, P., and Wilson, J.M. (2003) Lentiviral vectors pseudotyped with minimal filovirus envelopes increased gene transfer in murine lung. Mol. Ther. 8: 777-789.
130. Mehta, A. (2005) CFTR: more than just a chloride channel. Pediatr. Pulmonol. 39: 292-298.
131. Montier, T., Delepine, P., Pichon, C., Ferec, C., Porteous, D.J., and Midoux, P. (2004) Non-viral vectors in cystic fibrosis gene therapy: progress and challenges. Trends Biotechnol. 22: 586-592.
132. Moss, R.B., Rodman, D., Spencer, L.T., Aitken, M.L., Zeitlin, P.L., Waltz, D., Milla, C., Brody, A.S., Clancy, J.P., Ramsey, B., Hamblett, N., and Heald, A.E. (2004) Repeated adeno-associated virus serotype 2 aerosol-mediated cystic fibrosis transmembrane regulator gene transfer to the lungs of patients with cystic fibrosis: a multicenter, double-blind, placebo-controlled trial. Chest 125: 509-521.
133. Moss, R.B., Mayer-Hamblett, N., Wagener, J., Daines, C., Hale, K., Ahrens, R., Gibson, R.L., Anderson, P., Retsch-Bogart, G., Nasr, S.Z., Noth, I., Waltz, D., Zeitlin, P., Ramsey, B., and Starko, K. (2005) Randomized, double-blind, placebo-controlled, dose-escalating study of aerosolized interferon gamma-1b in patients with mild to moderate cystic fibrosis lung disease. Pediatr. Pulmonol. 39: 209-218.
134. Nagel, G., Barbry, P., Chabot, H., Brochiero, E., Hartung, K., and Grygorczyk, R. (2005) CFTR fails to inhibit the epithelial sodium channel ENaC expressed in Xenopus laevis oocytes. J. Physiol. 564: 671-82
135. Naldini, L., Blomer, U., Gallay, P., Ory, D., Mulligan, R., Gage, F.H., Verma, I.M., and Trono, D. (1996) In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science 272: 263-267.
136. Noone, P.G., Hohneker, K.W., Zhou, Z., Johnson, L.G., Foy, C., Gipson, C., Jones, K., Noah, T.L., Leigh, M.W., Schwartzbach, C., Efthimiou, J., Pearlman, R., Boucher, R.C., and Knowles, M.R. (2000) Safety and biological efficacy of a lipid-CFTR complex for gene transfer in the nasal epithelium of adult patients with cystic fibrosis. Mol. Ther. 1: 105-114.
137. O'Dea, S., and Harrison, D.J. (2002) CFTR gene transfer to lung epithelium-on the trail of a target cell. Curr. Gene Ther. 2: 173-181.
138. Olsen, J.C., Johnson, L.G., Stutts, M.J., Sarkadi, B., Yankaskas, J.R., Swanstrom, R., and Boucher, R.C. (1992) Correction of the apical membrane chloride permeability defect in polarized cystic fibrosis airway epithelia following retroviral-mediated gene transfer. Hum. Gene Ther. 3: 253-266.
139. Olsen, J.C. (1998) Gene transfer vectors derived from equine infectious anemia virus. Gene Ther. 5: 1481-1487.
140. Ostedgaard, L.S., Rokhlina, T., Karp, P.H., Lashmit, P., Afione, S., Schmidt, M., Zabner, J., Stinski, M.F., Chiorini, J.A., and Welsh, M.J. (2005) A shortened adeno-associated virus expression cassette for CFTR gene transfer to cystic fibrosis airway epithelia. Proc. Natl. Acad. Sci. USA 102: 2952-2957.
141. Parsons, D.W., Grubb, B.R., Johnson, L.G., and Boucher, R.C. (1998) Enhanced in vivo airway gene transfer via transient modification of host barrier properties with a surface-active agent. Hum. Gene Ther. 9: 2661-2672.
142. Parsons, D.W., Hopkins, P.J., Bourne, A.J., Boucher, R.C., and Martin, A.J. (2000) Airway gene transfer in mouse nasal-airways: importance of identification of epithelial type for assessment of gene transfer. Gene
143. Parsons, D.W. (2005) Airway gene therapy and cystic fibrosis. J. Paediatr. Child Health 41: 94-96.
144. Peebles, D., Gregory, L.G., David, A., Themis, M., Waddington, S.N., Knapton, H.J., Miah, M., Cook, T., Lawrence, L., Nivsarkar, M., Rodeck, C., and Coutelle, C. (2004) Widespread and efficient marker gene expression in the airway epithelia of fetal sheep after minimally invasive tracheal application of recombinant adenovirus in utero. Gene Ther. 11: 70-78.
145. Penque, D., Mendes, F., Beck, S., Farinha, C., Pacheco, P., Nogueira, P., Lavinha, J., Malho, R., and Amaral, M.D. (2000) Cystic fibrosis F508del patients have apically localized CFTR in a reduced number of airway cells. Lab Invest. 80: 857-868.
146. Perez-Vilar, J., and Boucher, R.C. (2004) Reevaluating gel-forming mucins' roles in cystic fibrosis lung disease. Free Radic. Biol. Med. 37: 1564-1577.
147. Perricone, M.A., Rees, D.D., Sacks, C.R., Smith, K.A., Kaplan, J.M., and St George, J.A. (2000) Inhibitory effect of cystic fibrosis sputum on adenovirus-mediated gene transfer in cultured epithelial cells. Hum. Gene Ther. 11: 1997-2008.
148. Pickles, R.J., Fahrner, J.A., Petrella, J.M., Boucher, R.C., and Bergelson, J.M. (2000) Retargeting the coxsackievirus and adenovirus receptor to the apical surface of polarized epithelial cells reveals the glycocalyx as a barrier to adenovirus-mediated gene transfer. J. Virol. 74: 6050-6057.
149. Pickles, R.J. (2004) Physical and biological barriers to viral vector-mediated delivery of genes to the airway epithelium. Proc. Am. Thorac. Soc. 1: 302-308.
150. Pier, G.B., Grout, M., Zaidi, T., Meluleni, G., Mueschenborn, S.S., Banting, G., Ratcliff, R., Evans, M.J., and Colledge, W.H. (1998) Salmonella typhi uses CFTR to enter intestinal epithelial cells. Nature 393: 79-82.
151. Poeschla, E.M., Wong-Staal, F., and Looney, D.J. (1998) Efficient transduction of nondividing human cells by feline immunodeficiency virus lentiviral vectors. Nat. Med. 4: 354-357.
152. Poynter, S.E., and LeVine, A.M. (2003) Surfactant biology and clinical application. Crit. Care Clin. 19: 459-472.
153. Pringle, I.A., Raman, S., Sharp, W.W., Cheng, S.H., Hyde, S.C., and Gill, D.R. (2005) Detection of plasmid DNA vectors following gene transfe0r to the murine airways. Gene Ther. 12: 1206-1214.
154. Reddy, R., Buckley, S., Doerken, M., Barsky, L., Weinberg, K., Anderson, K.D., Warburton, D., and Driscoll, B. (2004) Isolation of a putative progenitor subpopulation of alveolar epithelial type 2 cells. Am. J. Physiol. Lung Cell. Mol. Physiol. 286: L658-667.
155. Reynolds, S.D., Giangreco, A., Power, J.H., and Stripp, B.R. (2000) Neuroepithelial bodies of pulmonary airways serve as a reservoir of progenito0r cells capable of epithelial regeneration. Am. J. Pathol. 156: 269-278.
156. Rich, D.P., Anderson, M.P., Gregory, R.J., Cheng, S.H., Paul, S., Jefferson, D.M., McCann, J.D., Klinger, K.W., Smith, A.E., and Welsh, M.J. (1990) Expression of cystic fibrosis transmembrane conductance regulator corrects defective chloride channel regulation in cystic fibrosis airway epithelial cells. Nature 347: 358-363.
157. Rich, D.P., Couture, L.A, Cardoza, L.M., Guiggio, V.M., Armentano, D., Espino, P.C., Hehir, K., Welsh, M.J., Smith, A.E., and Gregory, R.J. (1993) Development and analysis of recombinant adenoviruses for gene therapy of cystic fibrosis. Hum. Gene Ther. 4: 461-476.
158. Rommens, J.M., Iannuzzi, M.C., Kerem, B., Drumm, M.L., Melmer, G., Dean, M., Rozmahel, R., Cole, J.L., Kennedy, D., Hidaka, N, Zsiga, M., Buchwald, M., Riordan, J.R., Tsui, L.-C., and Collins, F.S. (1989) Identification of the cystic fibrosis gene: Chromosome walking and jumping. Science 245: 1059-1065
159. Rose, A.C., Goddard, C.A., Colledge, W.H., Cheng, S.H., Gill, D.R., and Hyde, S.C. (2002) Optimisation of real-time quantitative RT-PCR for the evaluation of non-viral mediated gene transfer to the airways. Gene Ther. 9: 1312-1320.
160. Rubenstein, R.C. (2005) Novel, mechanism-based therapies for cystic fibrosis. Curr. Opin. Pediatr. 17: 385-392.
161. Saiman, L., Marshall, B.C., Mayer-Hamblett, N., Burns, J.L., Quittner, A.L., Cibene, D.A., Coquillette, S., Fieberg, A.Y., Accurso, F.J., and Campbell, P.W. (2003) Azithromycin in patients with cystic fibrosis chronically infected with Pseudomonas aeruginosa: a randomized controlled trial. JAMA 290: 1749-1756.
162. Sanders, N.N., De Smedt, S.C., Van Rompaey, E., Simoens, P., De Baets, F., and Derneester, J. (2000) Cystic fibrosis sputum: a barrier to the transport of nanospheres. Am. J. Respir. Crit. Care Med. 162: 1905-1911.
163. Schnepp, B.C., Jensen, R.L., Chen, C.L., Johnson, P.R., and Clark, K.R. (2005) Characterization of adeno-associated virus genomes isolated from human tissues. J. Virol. 79: 14793-14803.
164. Schoch, K.G., Lori, A., Burns, K.A., Eldred, T., Olsen, J.C., and Randell, S.H. (2004) A subset of mouse tracheal epithelial basal cells generates large colonies in vitro. Am. J. Physiol Lung Cell Mol. Physiol. 286: L631-L642.
165. chrijver, I., Oitmaa, E., Metspalu, A., and Gardner, P. (2005) Genotyping Microarray for the Detection of More Than 200 CFTR Mutations in Ethnically Diverse Populations. J. Mol. Diagn. 7: 375-387.
166. Schroeder, S.A., Gaughan, D.M., and Swift, M. (1995) Protection against bronchial asthma by CFTR delta F508 mutation: a heterozygote advantage in cystic fibrosis. Nat. Med. 1: 703-705.
167. Seidner, S.R., Jobe, A.H., Ikegami, M., Pettenazzo, A., Priestley, A., and Ruffini, L. (1988) Lysophosphatidylcholine uptake and metabolism in the adult rabbit lung. Biochim. Biophys. Acta. 961: 328-336.
168. Seiler, M.P., Luner, P., Moninger, T.O., Karp, P.H., Keshavjee, S., and Zabner, J. (2002) Thixotropic solutions enhance viral-mediated gene transfer to airway epithelia. Am. J. Respir. Cell Mol. Biol. 27: 133-140.
169. Shaffer, T.H., Wolfson, M.R., and Clark, L.C. Jr. (1992) Liquid ventilation. Pediatr. Pulmonol. 14: 102-109.
170. Sinn, P.L., Shah, A.J., Donovan, M.D., and McCray, P.B. Jr. (2005) Viscoelastic gel formulations enhance airway epithelial gene transfer with viral vectors. Am. J. Respir. Cell Mol. Biol. 32: 404-410
171. Sirninger, J., Muller, C., Braag, S., Tang, Q., Yue, H., Detrisac, C., Ferkol, T., Guggino, W.B., and Flotte, T.R. (2004) Functional characterization of a recombinant adeno-associated virus 5-pseudotyped cystic fibrosis transmembrane conductance regulator vector. Hum. Gene Ther. 15: 832-841.
172. Snouwaert, J.N., Brigman, K.K., Latour, A.M., Iraj, E., Schwab, U., Gilmour, M.I., and Koller, B.H. (1995) A murine model of cystic fibrosis. Am. J. Respir. Crit. Care Med 151: S59-S64.
173. Song, Y., Salinas, D., Nielson, D.W., and Verkman, A.S. (2005) Hyperacidity of secreted fluid from submucosal glands in early cystic fibrosis. Am. J. Physiol. Cell Physiol. [Epub ahead of print].
174. Stonebraker, J.R., Wagner, D., Lefensty, R.W., Burns, K., Gendler, S.J., Bergelson, J.M., Boucher, R.C., O'Neal, W.K., and Pickles, R.J. (2004) Glycocalyx restricts adenoviral vector access to apical receptors expressed on respiratory epithelium in vitro and in vivo: role for tethered mucins as barriers to lumenal infection. J. Virol. 78: 13755-13768.
175. Stutts, M.J., Canessa, C.M., Olsen, J.C., Hamrick, M., Cohn, J.A., Rossier, B.C., and Boucher, R.C. (1995) CFTR as a cAMP-dependent regulator of sodium channels. Science 269: 847-850.
176. Summerford, C., and Samulski, R.J. (1998) Membrane-associated heparan sulfate proteoglycan is a receptor for adeno-associated virus type 2 virions. J. Virol. 72: 1438-1445.
177. Suri, R. (2005) The use of human deoxyribonuclease (rhDNase) in the management of cystic fibrosis. BioDrugs 19: 135-44.
178. Tarran, R., Grubb, B.R., Parsons D., Picher, M., Hirsh, A.J., Davis, C.W., and Boucher, R.C. (2001) The CF salt controversy: In vivo observations and therapeutic approaches. Mol. Cell 8: 149-158.
179. 2+ -activated Cl- conductances. J. Gen. Physiol. 120: 407-418.
180. Tizzano, E.F., O'Brodovich, H., Chitayat, D., Benichou, J.C., and Buchwald, M. (1994) Regional expression of CFTR in developing human respiratory tissues. Am. J. Respir. Cell. Mol. Biol. 10: 355-362.
181. Trapnell, B.C., Chu, C.S., Paakko, P.K., Banks, T.C., Yoshimura, K., Ferrans, V.J., Chernick, M.S., and Crystal, R.G. (1991) Expression of the cystic fibrosis transmembrane conductance regulator gene in the respiratory tract of normal individuals and individuals with cystic fibrosis. Proc. Natl. Acad. Sci. USA 88: 6565-6569.
182. Trezise, A.E., Chambers, J.A., Wardle, C.J., Gould, S., and Harris, A. (1993) Expression of the cystic fibrosis gene in human foetal tissues. Hum. Mol. Genet. 2: 213-218.
183. Turelli, P., Doucas, V., Craig, E., Mangeat, B., Klages, N., Evans, R., Kalpana, G., and Trono, D. (2001) Cytoplasmic recruitment of INI1 and PML on incoming HIV preintegration complexes: interference with early steps of viral replication. Mol. Cell. 7: 1245-1254.
184. Turelli, P., and Trono, D. (2005) Editing at the crossroad of innate and adaptive immunity. Science 307: 1061-1065.
185. Vadolas, J., Williamson, R., and Ioannou, P.A. (2002) Gene therapy for inherited lung disorders: an insight into pulmonary defence. Pulm. Pharmacol. Ther. 15: 61-72.
186. van Heeckeren, A., Ferkol, T., and Tosi, M. (1998) Effects of bronchopulmonary inflammation induced by pseudomonas aeruginosa on adenovirus-mediated gene transfer to airway epithelial cells in mice. Gene Ther. 5: 345-351.
187. Van Heeckeren, A.M., Scaria, A., Schluchter, M.D., Ferkol, T.W., Wadsworth, S., and Davis, P.B. (2004) Delivery of CFTR by adenoviral vector to cystic fibrosis mouse lung in a model of chronic Pseudomonas aeruginosa lung infection. Am. J. Physiol Lung Cell Mol Physiol. 286: L717-L726.
188. Vankeerberghen. A., Cuppens, H., and Cassiman, J.J. (2002) The cystic fibrosis transmembrane conductance regulator: an intriguing protein with pleiotropic functions. J Cyst. Fibros. 1: 13-29.
189. Velsor, L.W., van Heeckeren, A., and Day, B.J. (2001) Antioxidant imbalance in the lungs of cystic fibrosis transmembrane conductance regulator protein mutant mice. Am. J. Physiol. Lung Cell. Mol. Physiol. 281: L31-138.
190. Vergani, P., Lockless, S.W., Nairn, A.C., and Gadsby, D.C. (2005) CFTR channel opening by ATP-driven tight dimerization of its nucleotide-binding domains. Nature 433: 876-880.
191. Verkman, A.S., Song, Y., and Thiagarajah, J.R. (2003) Role of airway surface liquid and submucosal glands in cystic fibrosis lung disease. Am. J. Physiol. Cell Physiol. 284: C2-15.
192. Virella-Lowell, I., Poirier, A., Chesnut, K.A., Brantly, M., and Flotte, T.R. (2000) Inhibition of recombinant adeno-associated virus (rAAV) transduction by bronchial secretions from cystic fibrosis patients. Gene Ther. 7: 1783-1789.
193. Virella-Lowell, I., Zusman, B., Foust, K., Loiler, S., Conlon, T., Song, S., Chesnut, K.A., Ferkol, T., and Flotte, T.R. (2005) Enhancing rAAV vector expression in the lung. J. Gene Med. 7: 842-850.
194. Wagner, J.A., Messner, A.H., Moran, M.L., Daifuku, R., Kouyama, K., Desch, J.K., Manley, S., Norbash, A.M., Conrad, C.K., Friborg, S., Reynolds, T., Guggino, W.B., Moss, R.B., Carter, B.J., Wine, J.J., Flotte, T.R., and Gardner, P. (1999) Safety and biological efficacy of an adeno-associated virus vector-cystic fibrosis transmembrane regulator (AAV-CFTR) in the cystic fibrosis maxillary sinus. Laryngoscope 109: 266-274.
195. Wagner, J.A., Nepomuceno, I.B., Messner, A.H., Moran, M.L., Batson, E.P., Dimiceli, S., Brown, B.W., Desch, J.K., Norbash, A.M., Conrad, C.K., Guggino, W.B., Flotte, T.R., Wine, J.J., Carter, B.J., Reynolds, T.C., Moss, R.B., and Gardner, P. (2002) A phase II, double-blind, randomized, placebo-controlled clinical trial of tgAAVCF using maxillary sinus delivery in patients with cystic fibrosis with antrostomies. Hum. Gene Ther. 13: 1349-1359.
196. Walker, L.C., Venglarik, C.J., Aubin, G., Weatherly, M.R., McCarty, N.A., Lesnick, B., Ruiz, F., Clancy, J.P., and Sorscher, E.J. (1997) Relationship between airway ion transport and a mild pulmonary disease mutation in CFTR. Am. J. Respir. Crit. Care Med. 155: 1684-1689.
197. Walters, R.W., Duan, D., Engelhardt, J.F., and Welsh, M.J. (2000) Incorporation of adeno-associated virus in a calcium phosphate coprecipitate improves gene transfer to airway epithelia in vitro and in vivo. J. Virol. 74: 535-540.
198. Walters, R.W., Yi, S.M., Keshavjee, S., Brown, K.E., Welsh, M.J., Chiorini, J.A., and Zabner, J. (2001) Binding of adeno-associated virus type 5 to 2,3-linked sialic acid is required for gene transfer. J. Biol. Chem. 276: 20610-20616.
199. Walters, R.W., Pilewski, J.M., Chiorini, J.A., and Zabner, J. (2002) Secreted and transmembrane mucins inhibit gene transfer with AAV4 more efficiently than AAV5. J Biol. Chem. 277: 23709-23713.
200. Wang, G., Davidson, B.L., Melchert, P., Slepushkin, V.A., van Es, H.H., Bodner, M., Jolly, D.J., and McCray, P.B. Jr. (1998) Influence of cell polarity on retrovirus-mediated gene transfer to differentiated human airway epithelia. J. Virol. 72: 9818-9826.
201. Wang, D., Fischer, H., Zhang, L., Fan, P., Ding, R.X., and Dong, J. (1999a) Efficient CFTR expression from AAV vectors packaged with promoters - the second generation. Gene Ther. 6: 667-675.
202. Wang, G., Slepushkin, V., Zabner, J., Keshavjee, S., Johnston, J.C., Sauter, S.L., Jolly, D.J., Dubensky, T.W. Jr., Davidson, B.L., and McCray, P.B. Jr. (1999b) Feline immunodeficiency virus vectors persistently transduce nondividing airway epithelia and correct the cystic fibrosis defect. J. Clin. Invest. 104: R55-R62.
203. Wang, G., Bunnell, B.A., Painter, R.G., Quiniones, B.C., Tom, S., Lanson, N.A. Jr., Spees, J.L., Bertucci, D., Peister, A., Weiss, D.J., Valentine, V.G., Prockop, D.J., and Kolls, J.K. (2005) Adult stem cells from bone marrow stroma differentiate into airway epithelial cells: potential therapy for cystic fibrosis. Proc. Natl. Acad. Sci. USA 102: 186-191.
204. Wark, P., McDonald, V., and Jones, A. (2005) Nebulised hypertonic saline for cystic fibrosis. Cochrane Database Syst. Rev. 20: CD001506.
205. Wei, B.L., Denton, P.W., O'Neill, E., Luo, T., Foster, J.L., and Garcia, J.V. (2005) Inhibition of lysosome and protessome function enhances human immunodeficiency virus type 1 infection. J. Virol. 79: 5705-5712.
206. Weiss, D.J., Strandjord, T.P., Jackson, J.C., Clark, J.G., and Liggitt, D. (1999a) Perfluorochemical liquid-enhanced adenoviral vector distribution and expression in lungs of spontaneously breathing rodents. Exp. Lung Res. 25: 317-333.
207. Weiss, D.J., Strandjord, T.P., Liggitt, D., and Clark, J.G. (1999b) Perflubron enhances adenovirus-mediated gene expression in lungs of transgenic mice with chronic alveolar filling. Hum. Gene Ther. 10: 2287-2293.
208. Weiss, D.J., Bonneau, L., Allen, J.M., Miller, A.D., and Halbert, C.L. (2000) Perfluorochemical liquid enhances adeno-associated virus-mediated transgene expression in lungs. Mol. Ther. 2: 624-630.
209. Weiss, D.J., Baskin, G.B., Shean, M.K., Blanchard, J.L., and Kolls, J.K. (2002a) Use of perflubron to enhance lung gene expression: safety and initial efficacy studies in non-human primates. Mol. Ther. 5: 8-5.
210. Weiss, D.J., Mutlu, G.M., Bonneau, L., Mendez, M., Wang, Y., Dumasius, V., and Factor, P. (2002b) Comparison of surfactant and perfluorochemical liquid enhanced adenovirus-mediated gene transfer in normal rat lung. Mol. Ther. 6: 43-49.
211. Weiss, D.J., Beckett, T., Bonneau, L., Young, J., Kolls, J.K., and Wang, G. (2003) Transient increase in lung epithelial tight junction permeability: an additional mechanism for enhancement of lung transgene expression by perfluorochemical liquids. Mol. Ther. 8: 927-935.
212. Weiss, D.J., and Pilewski, J.M. (2003) The status of gene therapy for cystic fibrosis. Semin. Respir. Crit. Care Med. 24: 749-770.
213. Weiss, D.J. (2004) Delivery of DNA to lung airway epithelium. Methods Mol. Biol. 246: 53-68.
214. Welsh, M.J., Ramsey, B.W., Accurso, F., and Cutting, G.R. (2001) Cystic Fibrosis. In: The Metabolic and Molecular Bases of Inherited Disease, 8th Edition, Eds. Scriver, C.R., Beaudet, A.L., Sly, W.S. & Valle, D. McGraw-Hill, New York.
215. Worgall, S., Leopold, P.L., Wolff, G., Ferris, B., Van Roijen, N., and Crystal, R.G. (1997) Role of alveolar macrophages in rapid elimination of adenovirus vectors administered to the epithelial surface of the respiratory tract. Hum. Gene Ther. 8: 1675-1684.
216. Xiao, X., Li, J., and Samulski, R.J. (1998) Production of high-titer recombinant adeno-associated virus vectors in the absence of helper adenovirus. J. Virol. 72: 2224-2232.
217. Yan, Z., Zak, R., Zhang, Y., Ding, W., Godwin, S., Munson, K., Peluso, R., and Engelhardt, J.F. (2004) Distinct classes of proteasome-modulating agents cooperatively augment recombinant adeno-associated virus type 2 and type 5-mediated transduction from the apical surfaces of human airway epithelia. J. Virol. 78: 2863-74.
218. Yang, Z.Y., Duckers, H.J., Sullivan, N.J., Sanchez, A., Nabel, E.G., and Nabel, G.J. (2000) Identification of the Ebola virus glycoprotein as the main viral determinant of vascular cell cytotoxicity and injury. Nat. Med. 6: 886-889.
219. Yap, M.W., Nisole, S., Lynch, C., and Stoye, J.P. (2004) Trim5alpha protein restricts both HIV-1 and murine leukemia virus. Proc. Natl. Acad. Sci. USA 101: 10786-10791.
220. Zabner, J., Ramsey, B.W., Meeker, D.P., Aitken, M.L., Balfour, R.P., Gibson, R.L., Launspach, J., Moscicki, R.A., Richards, S.M., Standaert, T.A., William-Warren, J., Wadsworth, S.C., Smith, A.E., and Welsh, M.J. (1996a) Repeat administration of an adenovirus vector encoding cystic fibrosis transmembrane conductance regulator to the nasal epithelium of patients with cystic fibrosis. J. Clin. Invest. 97: 1504-1511.
221. Zabner, J., Zeiher, B.G., Friedman, E., and Welsh, M.J. (1996b) Adenovirus-mediated gene transfer to ciliated airway epithelia requires prolonged incubation time. J. Virol. 70: 6994-7003.
222. Zabner, J., Seiler, M., Walters, R., Kotin, R.M., Fulgeras, W., Davidson, B.L., and Chiorini, J.A. (2000) Adeno-associated virus type 5 (AAV5) but not AAV2 binds to the apical surfaces of airway epithelia and facilitates gene transfer. J. Virol. 74: 3852-3858.
223. Zhang, L., Wang, D., Fischer, H., Fan, P.D., Widdicombe, J.H., Kan, Y.W., and Dong, J.Y. (1998) Efficient expression of CFTR function with adeno-associated virus vectors that carry shortened CFTR genes. Proc. Natl. Acad. Sci. USA 95: 10158-10163.
224. Zhou, L., Dey, C.R., Wert, S.E., DuVall, M.D., Frizzell, R.A., and Whitsett, J.A. (1994) Correction of lethal intestinal defect in a mouse model of cystic fibrosis by human CFTR. Science 266: 1705-1708.
225. Ziady, A.G., Kelley, T.J., Milliken, E., Ferkol, T., and Davis, P.B. (2002) Functional evidence of CFTR gene transfer in nasal epithelium of cystic fibrosis mice in vivo following luminal application of DNA complexes targeted to the serpin-enzyme complex receptor. Mol. Ther. 5: 413-419.
226. Ziady, A.G., Davis, P.B., and Konstan, M.W. (2003) Non-viral gene transfer therapy for cystic fibrosis. Expert Opin. Biol. Ther. 3: 449-458.